Cyprus – Medicinal products for the blood and blood-forming organs – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
Υπουργείο Υγείας
Buyer country
Cyprus
Publication date
Not specified
Biderra sector
Pharma and laboratory
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 86%
- Official title coverage
- 7 languages
- Classification signal
- 33621000
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Chipre – Medicamentos para la sangre y para los órganos hematopoyéticos – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
Cyprus – Geneesmiddelen voor bloed en bloedvormende organen – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
Cypr – Produkty lecznicze dla krwi oraz organów krwiotwórczych – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
Chypre – Médicaments du sang et des organes hématopoïétiques – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
Zypern – Arzneimittel für Blut und Blut bildende Organe – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
Cipro – Medicinali per il sangue e gli organi che formano il sangue – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
Cyprus – Medicinal products for the blood and blood-forming organs – Προσφορά για την προμήθεια Heparin Sodium και Tirofiban Φ.Υ.Υ 50/2026-ΟKΥπΥ
What Biderra adds
For notice 593980-2026, Biderra has normalized the contracting authority country as Cyprus, grouped CPV 33621000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.